Sofia, Bulgaria, July 7, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that in accordance with аrt. 25 of the Articles of incorporation of the Company, the Board of Directors adopted a decision for issuance, under the conditions of initial public offering, of warrants as follows:

Exercise price: BGN 6.10

Issuance price of one warrant: BGN 0.48

Number of warrants: 26 959 580

Minimum success threshold of the issue: 13 479 790

Term in which the right can be exercised: 5 years

Sofia, Bulgaria, July 5, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for June 2022 the Company recorded an increase in sales of 83% compared to the same month of the previous year, incl. 39% increase in domestic sales and 109% increase in export sales.

For the six months since the beginning of the year the revenues from sales of products increase by 37%, incl. 35% increase of sales for the domestic market and 38% increase in export sales.